Neurostimulation – our new study reveals trends, R&D progress, and predicted revenues
Where is the Neurostimulation market heading? If you are involved in this sector you must read this brand new report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 178-page report provides 102 tables, charts, and graphs, providing over 2900 unique datapoints. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Neurostimulation market. See how to exploit the opportunities.
Forecasts to 2027 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are forecasts for 6 Neurostimulation Products and 7 Neurostimulation Applications, each forecasted at a global, regional and national level.
Neurostimulation Software, by Product
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Cortical Stimulators
• Others
Neurostimulation, by Application
• Pain Management
• Epilepsy
• Urinary and Fecal Incontinence
• Hearing Loss
• Gastroparesis
• Parkinson’s Disease
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 6 regional and 10 leading national markets:
• North America:
• The US
• Canada
• Europe:
• Germany
• The UK
• Italy
• Spain
• France
• Rest of Europe
• APAC:
• Japan
• China
• India
• Rest of Asia-Pacific
• RoW:
• Latin America
• Middle East and Africa
• Other Countries
The report also includes profiles and for some of the leading companies in the Neurostimulation market, with a focus on the Neurostimulation segment of these companies’ operations.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and the US in particular, will continue to achieve high revenue growth to 2027.
Leading companies and the potential for market growth
Overall world revenue for Neurostimulation will surpass $19bn in 2027, our work calculates. We predict strong revenue growth through to 2027. With increasing incidence of neurological diseases, the demand for neurostimulation devices is expected to increase significantly in the next few years.
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Neurostimulation Market report helps you
In summary, our 178-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for the Neurostimulation market and 2 different segmentations, with forecasts for 6 Products and 7 Applications at a Global, Regional and National level – discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 6 regional and 10 key national markets – North America, Europe, Asia-Pacific, Latin America, Middle East and Africa are forecasted, as well as the US, Canada, Germany, France, the UK, Italy, Spain, Japan, China, India,
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market – including company profiles for 10 companies involved in the Neurostimulation market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.
Visiongain’s study is for everybody needing commercial analyses for the Neurostimulation market and leading companies. You will find data, trends and predictions.
Get our report today Neurostimulation Devices Market 2017-2027: Forecasts by Product (Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Cortical Stimulators and Others), by Application (Epilepsy, Pain Management, Hearing Loss, Incontinence, Gastroparesis, Parkinson’s Disease and Others) and Geography. Avoid missing out – get our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 Why You Should Read This Report
1.2 How This Report Delivers
1.3 Key Questions Answered by This Analytical Report Include:
1.4 Who is This Report For?
1.5 Methodology
1.5.1 Primary Research
1.5.2 Secondary Research
1.5.3 Market Evaluation & Forecasting Methodology
1.6 Frequently Asked Questions (FAQ)
1.7 Associated Visiongain Reports
1.8 About Visiongain
2. Introduction to the Neurostimulation Devices Market
2.1 Classification of Neurostimulation Devices
2.2 What are Neurostimulation Devices?
2.3 Regulation of Medical Devices?
2.3.1 The US Approval and Regulation System
2.3.2 The EU Approval and Regulation System
2.3.3 China Approval and Regulation System
2.3.4 Japan Approval and Regulation System
2.3.5 India Approval and Regulation System
3. Neurostimulation Devices Market: Drivers & Restraints
3.1 Driving Factors
3.1.1 Growing prevalence of neurological disorders
3.1.2 Increasing Growth of Aging Population
3.1.3 Changing Lifestyle and growing obesity
3.1.4 Various opportunities from emerging markets
3.2 Market Restraints
3.2.1 Shortage of neurologists to treat an increasing number of neurologic patients
3.2.2 Uncertain outcomes of changing healthcare policies
3.2.3 Imposition of the medical device excise tax in the U.S.
3.2.4 Poor primary healthcare infrastructure and lack of healthcare insurance in developing countries
4. Global Neurostimulation Devices Market, By Product, 2017-2027
4.1 Spinal Cord Stimulators Market Forecast 2017-2027
4.2 Deep Brain Stimulators Market Forecast 2017-2027
4.3 Vagus Nerve Stimulators Market Forecast 2017-2027
4.4 Sacral Nerve Stimulators Market Forecast 2017-2027
4.5 Cortical Stimulators Market Forecast 2017-2027
4.6 Other Neurostimulation Devices Market Forecast 2017-2027
5. Global Neurostimulation Devices Market, By Application, 2017-2027
5.1 Epilepsy Neurostimulation Devices Market Forecast 2017-2027
5.2 Pain Management Neurostimulation Devices Market Forecast 2017-2027
5.3 Hearing Loss Neurostimulation Devices Market Forecast 2017-2027
5.4 Urinary and Fecal Incontinence Neurostimulation Devices Market Forecast 2017-2027
5.5 Gastroparesis Neurostimulation Devices Market Forecast 2017-2027
5.6 Parkinson’s Disease Neurostimulation Devices Market Forecast 2017-2027
5.7 Others Application Market Forecast 2017-2027
6. Global Neurostimulation Devices Market, By Region, 2017-2027
6.1 Introduction
6.2 Regional Breakdown of the Global Neurostimulation Devices Market
6.3 How will Regional Market Shares Change to 2027?
6.4 North America Neurostimulation Devices Market 2017-2027
6.4.1 U.S. Neurostimulation Devices Market Forecast 2017-2027
6.4.2 Canada Neurostimulation Devices Market Forecast 2017-2027
6.5 Europe Neurostimulation Devices Market Forecast 2017-2027
6.5.1 Germany Neurostimulation Devices Market Forecast 2017-2027
6.5.2 France Neurostimulation Devices Market Forecast 2017-2027
6.5.3 UK Neurostimulation Devices Market Forecast 2017-2027
6.5.4 Italy Neurostimulation Devices Market Forecast 2017-2027
6.5.5 Spain Neurostimulation Devices Market Forecast 2017-2027
6.5.6 Rest of Europe (RoE)
6.6 Asia-Pacific Neurostimulation Devices Market Forecast 2017-2027
6.6.1 Japan Neurostimulation Devices Market Forecast 2017-2027
6.6.2 China Neurostimulation Devices Market Forecast 2017-2027
6.6.3 India Neurostimulation Devices Market Forecast 2017-2027
6.6.4 Rest of Asia-pacific Neurostimulation Devices Market Forecast 2017-2027
6.7 Rest of the World Neurostimulation Devices Market Forecast 2017-2027
6.7.1 Latin America Neurostimulation Devices Market Forecast 2017-2027
6.7.2 Middle East & Africa Neurostimulation Devices Market Forecast 2017-2027
7. Leading Companies in the Neurostimulation Devices Market
7.1 Advanced Bionics, LLC
7.1.1 Overview
7.1.2 Financials
7.1.3 Product Portfolio
7.1.4 Developments
7.2 Boston Scientific Corporation
7.2.1 Overview
7.2.2 Financials
7.2.3 Product portfolio
7.2.4 Developments
7.3 Cochlear Ltd.
7.3.1 Overview
7.3.2 Financials
7.3.3 Product Portfolio
7.3.4 Developments
7.4 Cyberonics
7.4.1 Overview
7.4.2 Financials
7.4.3 Products Portfolio
7.4.4 Developments
7.5 Medtronic plc
7.5.1 Overview
7.5.2 Financials
7.5.3 Product Portfolio
7.5.4 Developments
7.6 Neuronetics, Inc.
7.6.1 Overview
7.6.2 Financials
7.6.3 Product Portfolio
7.6.4 Developments
7.7 Nevro Corp.
7.7.1 Overview
7.7.2 Financials
7.7.3 Product Portfolio
7.7.4 Developments
7.8 Cogentix Medical Inc
7.8.1 Overview
7.8.2 Financials
7.8.3 Product Portfolio
7.8.4 Developments
7.9 St. Jude Medical
7.9.1 Overview
7.9.2 Financials
7.9.3 Product Portfolio
7.9.4 Developments
7.10 NDI Medical, llc.
7.10.1 Overview
7.10.2 Product portfolio
7.10.3 Developments
7.11 Other Companies of Interest Neurostimulation Devices Market
8. The Global Neurostimulation Devices Market, Competitive Landscape
8.1 New Product Launches
8.2 Acquisitions, Collaborations, and Partnerships
8.3 Other Developments
9. Conclusions
9.1 Top Neurostimulation Devices Market
9.2 Top Neurostimulation Devices Applications Market
9.3 Top Nations Neurostimulation in the Devices Market
10. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
List of Figures
Figure 2.1 Neurostimulation Devices Market Segmentation
Figure 2.2 Stages of regulatory control
Figure 3.1 Neurostimulation Devices Market: Drivers and Restraints, 2017-202
Figure 3.2 Share of geriatric population, by region, 2010-2020
Figure 4.1 Neurostimulation Devices Submarkets by Product: Forecast Revenue ($m) and CAGR (%) 2017-2027
Figure 4.2 Spinal Cord Stimulators Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
Figure 4.3 Deep Brain Stimulators Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
Figure 4.4 Vagus Nerve Stimulators Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
Figure 4.5 Sacral Nerve Stimulators Devices Markets by Region: Forecast ($m), 2017-2027
Figure 4.6 Cortical Stimulators by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
Figure 4.7 Other Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
Figure 5.1 Neurostimulation Devices Markets by Application: Forecast Revenue ($m) and CAGR (%) 2017-2027
Figure 5.2 Epilepsy Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
Figure 5.3 Pain Management Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
Figure 5.4 Hearing Loss Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
Figure 5.6 Urinary and Fecal Incontinence Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
Figure 5.7 Gastroparesis Neurostimulation devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
Figure 5.8 Parkinson’s Disease Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
Figure 5.9 Other Neurostimulation Devices Markets by Region: Forecast ($m), 2017-2027
Figure 6.1 Neurostimulation Devices Markets by Region: Forecast ($m), 2016
Figure 6.2 North America Neurostimulation Devices Markets by Country (%), 2017
Figure 6.3 U.S. Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
Figure 6.4 Increasing Prevalence Rate In Canada By Chronic Diseases, 2001-2039
Figure 6.5 Canada Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
Figure 6.6 Europe Neurostimulation Devices Markets by Country (%), 2017
Figure 6.7 Change in population structure in Germany, 1995-2015
Figure 6.8 Germany Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
Figure 6.9 France Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
Figure 6.10 U.K. Population estimates and projections, 2010-2040
Figure 6.11 U.K. Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
Figure 6.12 Italy Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
Figure 6.13 Spain Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
Figure 6.14 Asia-Pacific Neurostimulation Devices Markets by Country (%), 2017
Figure 6.15 Japan Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
Figure 6.16 Share of Aging population in total Chinese population, 2011-2016 (%)
Figure 6.17 China Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
Figure 6.18 India Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
Figure 6.19 Rest of the World Neurostimulation Devices Markets by Region (%), 2017
Figure 6.20 Latin America Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
Figure 6.21 Middle East and Africa Revenue Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
Figure 7.1 Advanced Bionics: Recent Financials, 2014-2016
Figure 7.2 Boston Scientific Corporation: Recent Financials, 2014-2016
Figure 7.3 Cochlear: Recent Financials, 2014-2016
Figure 7.4 Cyberonics: Recent Financials, 2014-2016
Figure 7.5 Medtronic: Recent Financials, 2014-2016
Figure 7.6 Nevro Corp: Recent Financials, 2014-2016
Figure 7.7 St. Jude Medical: Recent Financials, 2013-2015
Figure 9.1 Top Neurostimulation Devices Market
Figure 9.2Top Neurostimulation Devices Applications
Figure 9.3 Top Nations in the Neurostimulation Devices Market
List of Tables
Table 4.1 Neurostimulation Devices Submarkets by Product: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 4.2 Spinal Cord Stimulators Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 4.3 Deep Brain Stimulators by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 4.4 Vagus Nerve Stimulators Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 4.5 Sacral Nerve Stimulators Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 4.6 Cortical Stimulators Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 4.7 Other Neurostimulation devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 5.1 Neurostimulation devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 5.2 Epilepsy Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 5.3 Pain Management Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 5.4 Hearing Loss Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 5.6 Urinary and Fecal Incontinence Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 5.7 Gastroparesis Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 5.8 Parkinson’s Disease Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 5.9 Other Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 6.1 Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 6.2 North America Neurostimulation Devices Markets by Country: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 6.3 North America Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 6.4 North America Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 6.5 Europe Neurostimulation Devices Markets by Country: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 6.6 Europe Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 6.7 Europe Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 6.8 Asia-Pacific Neurostimulation Devices Markets by Country: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 6.9 Asia-PacificNeurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 6.10 Asia-PacificNeurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 6.11 Rest of the World Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 6.12 Rest of the World Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 6.13 Rest of the World Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2017-2027
Table 7.1 Advanced Bionics Product Portfolio
Table 7.2 Advanced Bionics: Developments
Table 7.3 Boston Scientific Corporation: Product Portfolio
Table 7.4 Boston Scientific Corporation: Developments
Table 7.5 Cochlear Ltd.: Product Portfolio
Table 7.6 Cochlear Ltd.: Developments
Table 7.7 Cyberonics.: Product Portfolio
Table 7.8 Cyberonics: Developments
Table 7.9 Medtronic: Product Portfolio
Table 7.10 Medtronic: Developments
Table 7.11 Neuronetics: Product Portfolio
Table 7.12 Neuronetics: Developments
Table 7.13 Nevro Corp: Product Portfolio
Table 7.14 Nevro Corp: Developments
Table 7.15 Cogentix Medical: Product Portfolio
Table 7.16 Cogentix Medical: Developments
Table 7.17 St. Jude Medical: Product Portfolio
Table 7.18 St. Jude Medical: Developments
Table 7.19 NDI Medical: Product Portfolio
Table 7.20 NDI Medical: Developments
Table 7.21 Other Companies in the Neurostimulation Devices Market
Table 7.21 Other Companies in the Neurostimulation Devices Market (continued)
Table 7.21 Other Companies in the Neurostimulation Devices Market (continued)
Table 7.21 Other Companies in the Neurostimulation Devices Market (continued)
Table 7.21 Other Companies in the Neurostimulation Devices Market (continued)
Table 8.1 New Product Launches
Table 8.2 Acquisitions, Collaborations, and Partnerships
Table 8.3 Other Developments
480 Biomedical Inc.
Abbott Laboratories
Accellent
Advanced Bionics, LLC
Advanced Neuromodulation Systems
Allergan Plc
Anterios, Inc.
Argon Medical Devices Inc.
B. Braun
Baxter International, Inc.
Bayer AG
BioControl Medical (B.C.M) Ltd.
BIOMED CENTRAL LTD
Bionx Medical Technologies Inc.
Boston Scientific Corporation
Canadian Institutes of Health Research
Carestream Health, Inc.
Cochlear Ltd.
Codman & Shurtleff, Inc.
Cogentix Medical
Cyberonics Inc.
Deep Brain Innovations
Edwards Lifesciences Corp.
EndoStim Inc.
EnteroMedics Inc
GE HEALTHCARE LTD
Globus Medical, Inc.
Helius Medical Technologies, Inc.
Hitachi Health Care Manufacturing K.K.
Hologic, Inc.
Inspire Medical Systems Inc.
IntraPace, Inc.
Johnson & Johnson
Johnson & Johnson Medical Limited
LifeTech Scientific Corp.
LivaNova PLC
Mainstay Medical International Plc
MED-EL
Medtronic Plc
Medtronic Usa Inc.
Mindray Medical International Ltd.
Natus Medical, Inc.
NDI Medical LLC
Neurologica Corp.
NeuroMetrix, Inc.
Neuronetics, Inc.
NeuroPace, Inc.
NeuroSigma, Inc.
Nevro Corp
Nexstim Oyj
Penumbra, Inc.
Pfizer Inc.
Quest Diagnostics
Roche Holding AG
Royal Philips NV
Siemens AG
Smith & Nephew Plc
Soterix Medical Inc
St. Jude Medical
Stryker Corp.
Synapse Biomedical Inc.
Terumo Corp.
Tesla, Inc.
Toshiba Medical Systems Corporation
XOGRAPH HEALTHCARE LTD
Zimmer Biomet Holdings, Inc.
List of Organisations
American Academy of Neurology
Chinese Food & Drug Administration (CFDA)
Federal Interagency Forum on Aging-Related Statistics
Food & Drug Administration (US)
International Labour Organization (ILO)
Ministry of Health, Labor and Welfare (MHLW)
National Health Service (UK)
Parkinson’s Disease Foundation
World Health Organisation (WHO)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
